This inventor holds 1 USPTO granted patent. Top assignee: Technische Universität München. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Deepak Prabhu Ramanujam: Innovator in Targeted Drug Delivery
Introduction
Deepak Prabhu Ramanujam is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the area of targeted drug delivery systems. His innovative work aims to improve treatment options for various diseases, including pulmonary fibrosis.
Latest Patents
Deepak holds a patent titled "Targeted Delivery of an Inhibitor of miR-21 to Macrophages for the Treatment of Pulmonary Fibrosis." This patent represents a breakthrough in the targeted delivery of therapeutic agents, which can enhance the efficacy of treatments while minimizing side effects. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Deepak is affiliated with the Technische Universität München, where he conducts research and collaborates with other experts in the field. His work at this prestigious institution has allowed him to explore innovative solutions to complex medical challenges. His dedication to research and development has positioned him as a key figure in his area of expertise.
Collaborations
One of his notable collaborators is Stefan Engelhardt. Together, they work on projects that aim to push the boundaries of current medical treatments and improve patient outcomes.
Conclusion
Deepak Prabhu Ramanujam is an influential inventor whose work in targeted drug delivery is paving the way for new therapeutic strategies. His contributions to the field are significant and hold promise for the future of medicine.